Intravitreal aflibercept injection for neovascular (wet) age-related macular degeneration

Drug delivery strategies for therapeutic angiogenesis and antiangiogenesis

(2011) Nupura S Bhise et al.   Expert Opinion on Drug Delivery

Myositis Ossificans

(2011) Deborah A. Martin et al.   NEW ENGLAND JOURNAL OF MEDICINE

Primary Endpoint Results of a Phase II Study of Vascular Endothelial Growth Factor Trap-Eye in Wet Age-related Macular Degeneration

(2011) David M. Brown et al.   OPHTHALMOLOGY

Safety and Efficacy of a Flexible Dosing Regimen of Ranibizumab in Neovascular Age-Related Macular Degeneration: The SUSTAIN Study

(2011) Frank G. Holz et al.   OPHTHALMOLOGY

The 1-year Results of CLEAR-IT 2, a Phase 2 Study of Vascular Endothelial Growth Factor Trap-Eye Dosed As-needed After 12-week Fixed Dosing

(2011) Jeffrey S. Heier et al.   OPHTHALMOLOGY

Ranibizumab Therapy for Neovascular Age-Related Macular Degeneration

(2010) James C. Folk et al.   NEW ENGLAND JOURNAL OF MEDICINE

VEGF Trap-Eye for the treatment of neovascular age-related macular degeneration

(2009) James A Dixon et al.   EXPERT OPINION ON INVESTIGATIONAL DRUGS

A Phase I Study of Intravitreal Vascular Endothelial Growth Factor Trap-Eye in Patients with Neovascular Age-Related Macular Degeneration

(2009) Quan Dong Nguyen et al.   OPHTHALMOLOGY

Randomized, Double-Masked, Sham-Controlled Trial of Ranibizumab for Neovascular Age-related Macular Degeneration: PIER Study Year 1

(2008) Carl D. Regillo et al.   AMERICAN JOURNAL OF OPHTHALMOLOGY

Predicted biological activity of intravitreal VEGF Trap

(2008) M W Stewart et al.   BRITISH JOURNAL OF OPHTHALMOLOGY

Ranibizumab versus Verteporfin Photodynamic Therapy for Neovascular Age-Related Macular Degeneration: Two-Year Results of the ANCHOR Study

(2008) David M. Brown et al.   OPHTHALMOLOGY

Aflibercept

(2008) &NA;   Drugs in research & development